![[Valid RSS]](images/valid-rss-rogers.png "Valid RSS")
This is a valid RSS feed.
This feed is valid, but interoperability with the widest range of feed readers could be improved by implementing the following recommendations.
<dc:date>2024-05-17T00:00:15Z</dc:date>
^
line 16, column 6: (4 occurrences) [help]
<dc:date>2024-04-01T00:00:00Z</dc:date>
^
</channel>
^
<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0"> <channel> <title>Kyoto University Research Information Repository</title> <link>https://repository.kulib.kyoto-u.ac.jp:443/dspace</link> <description>DSpaceはデジタル研究資料を収集・格納・索引・保存・配布するシステムです。</description> <pubDate>Fri, 17 May 2024 00:00:15 GMT</pubDate> <dc:date>2024-05-17T00:00:15Z</dc:date> <item> <title>2023(令和5)年度京都大学図書館機構活動報告</title> <link>http://hdl.handle.net/2433/287626</link> <description>タイトル: 2023(令和5)年度京都大学図書館機構活動報告著者: 京都大学図書館機構</description> <pubDate>Mon, 01 Apr 2024 00:00:00 GMT</pubDate> <guid isPermaLink="false">http://hdl.handle.net/2433/287626</guid> <dc:date>2024-04-01T00:00:00Z</dc:date> </item> <item> <title>Development of Art Fashion by Integrating Art and Digital Textile Printing</title> <link>http://hdl.handle.net/2433/287625</link> <description>タイトル: Development of Art Fashion by Integrating Art and Digital Textile Printing著者: Amo, Yuya; Jonoo, Minori; Rokudo, Miwa; Kawamura, Harumi; Maruyama, Saeko; Kozai, Akiko; Tosa, Naoko; Nakatsu, Ryohei抄録: Fashion and art are essential elements of our life because they enrich people’s daily lives. As art has a business model of small-scale production and fashion has a business model of mass production, there was little point of contact between the two. However, these two areas are approaching with the spread of digital art in the art world and the emergence of digital textile printing technology in the fashion world. Combining digital art and digital textile printing creates new possibilities for art to enter our everyday life as clothing. This paper describes our attempt to create fashion from digital art under the concept of “wearing art” through joint research between a university and a company.記述: Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering book series (LNICST, volume 479); 11th EAI International Conference, ArtsIT 2022, Faro, Portugal, November 21-22, 2022, Proceedings</description> <pubDate>Sun, 01 Jan 2023 00:00:00 GMT</pubDate> <guid isPermaLink="false">http://hdl.handle.net/2433/287625</guid> <dc:date>2023-01-01T00:00:00Z</dc:date> </item> <item> <title>Investigational regenerative medicine for non-traumatic osteonecrosis of the femoral head: a survey of registered clinical trials</title> <link>http://hdl.handle.net/2433/287624</link> <description>タイトル: Investigational regenerative medicine for non-traumatic osteonecrosis of the femoral head: a survey of registered clinical trials著者: Kuroda, Yutaka; Kawai, Toshiyuki; Okuzu, Yaichiro; Morita, Yugo; Matsuda, Shuichi抄録: Introduction: Osteonecrosis of the femoral head (ONFH) is a refractory disease requiring joint replacement in young patients. Regenerative therapies have been developed. Areas covered: This study surveyed clinical trials on regenerative medicine for ONFH. We extracted clinical trials on non-traumatic ONFH from the websites of five publicly available major registries (EuropeanUnion Clinical Trials Register ([EU-CTR], ClinicalTrials.gov, Chinese ClinicalTrial Registry [ChiCTR], University Hospital Medical InformationNetwork - Clinical Trial Registry [UMIN-CTR] and Australian New Zealand Clinical Trials Registry [ANZCTR]).The trials were classified into six categories based on purpose: surgical treatment, non-drug conservative treatment, conservative drug treatment, therapeutic strategy, diagnosis and pathogenesis, and regenerative therapy.) We extracted 169 clinical trials on ONFH. Of these, 37 were on regenerative medicine, including 29 on cell therapy. Surgical treatment was the most common treatment, followed by regenerative therapy.There were 9 clinical trials registered in the EU-CTR, with 5 on regenerative medicine; 79 trials registered on ClinicalTrials.gov, with 24 on regenerativemedicine; 54 trials registered in the ChiCTR, with 6 on regenerative medicine. Expert opinion: The focus of the joint-preserving surgery has shifted to regenerative therapy based on using cell therapy in early-stage ONFH. The global standardisation of regenerative therapy is still ongoing.</description> <pubDate>Mon, 01 Apr 2024 00:00:00 GMT</pubDate> <guid isPermaLink="false">http://hdl.handle.net/2433/287624</guid> <dc:date>2024-04-01T00:00:00Z</dc:date> </item> <item> <title>Micro-patterned culture of iPSC-derived alveolar and airway cells distinguishes SARS-CoV-2 variants.</title> <link>http://hdl.handle.net/2433/287623</link> <description>タイトル: Micro-patterned culture of iPSC-derived alveolar and airway cells distinguishes SARS-CoV-2 variants.著者: Masui, Atsushi; Hashimoto, Rina; Matsumura, Yasufumi; Yamamoto, Takuya; Nagao, Miki; Noda, Takeshi; Takayama, Kazuo; Gotoh, Shimpei抄録: The emergence of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) variants necessitated a rapid evaluation system for their pathogenesis. Lung epithelial cells are their entry points; however, in addition to their limited source, the culture of human alveolar epithelial cells is especially complicated. Induced pluripotent stem cells (iPSCs) are an alternative source of human primary stem cells. Here, we report a model for distinguishing SARS-CoV-2 variants at high resolution, using separately induced iPSC-derived alveolar and airway cells in micro-patterned culture plates. The position-specific signals induced the apical-out alveolar type 2 and multiciliated airway cells at the periphery and center of the colonies, respectively. The infection studies in each lineage enabled profiling of the pathogenesis of SARS-CoV-2 variants: infection efficiency, tropism to alveolar and airway lineages, and their responses. These results indicate that this culture system is suitable for predicting the pathogenesis of emergent SARS-CoV-2 variants.記述: iPS細胞から作った肺胞や気道の細胞によりSARS-CoV-2変異株の病原性を比較評価する. 京都大学プレスリリース. 2024-03-29.; Micro-patterning a new system to induce alveolar and airway epithelial cells. 京都大学プレスリリース. 2024-03-29.</description> <pubDate>Tue, 09 Apr 2024 00:00:00 GMT</pubDate> <guid isPermaLink="false">http://hdl.handle.net/2433/287623</guid> <dc:date>2024-04-09T00:00:00Z</dc:date> </item> </channel></rss> If you would like to create a banner that links to this page (i.e. this validation result), do the following:
Download the "valid RSS" banner.
Upload the image to your own server. (This step is important. Please do not link directly to the image on this server.)
Add this HTML to your page (change the image src attribute if necessary):
If you would like to create a text link instead, here is the URL you can use:
